Entheon Biomedical Corp. ENBI.CN Stock
0.13 CAD
{{ price }}
8.333332%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Canada
Exchange
Canadian Sec
Market Cap
768.16K CAD
LOW - HIGH [24H]
0.11
-
0.14 CAD
VOLUME [24H]
161.46K CAD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.05 CAD
Entheon Biomedical Corp. Price Chart
Entheon Biomedical Corp. ENBI.CN Financial and Trading Overview
| Entheon Biomedical Corp. stock price | 0.13 CAD |
| Previous Close | 0.03 CAD |
| Open | 0 CAD |
| Bid | 0.03 CAD x N/A |
| Ask | 0.04 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.1 CAD |
| Volume | 0 CAD |
| Avg. Volume | 21.62K CAD |
| Market Cap | 1.48M CAD |
| Beta (5Y Monthly) | 1.047719 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ENBI.CN Valuation Measures
| Enterprise Value | 972.51K CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.7702346 |
| Price/Book (mrq) | 2.777778 |
| Enterprise Value/Revenue | 3.14 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Entheon Biomedical Corp. Stock Price History
| Beta (5Y Monthly) | 1.047719 |
| 52-Week Change | -58.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.03 CAD |
| 200-Day Moving Average | 0.03 CAD |
ENBI.CN Share Statistics
| Avg. Volume (3 month) | 21.62K CAD |
| Avg. Daily Volume (10-Days) | 7.48K CAD |
| Shares Outstanding | 59.09M |
| Float | 57.19M |
| Short Ratio | 0.31 |
| % Held by Insiders | 8.63% |
| % Held by Institutions | 0% |
| Shares Short | 5.3K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | November 30, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | November 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -706.067% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.39% |
| Return on Equity (ttm) | -15.58% |
Income Statement
| Revenue (ttm) | 309.68K CAD |
| Revenue Per Share (ttm) | 0.005 CAD |
| Quarterly Revenue Growth (yoy) | 1248.19% |
| Gross Profit (ttm) | 189.68K CAD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -613608 CAD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 504.72K CAD |
| Total Cash Per Share (mrq) | 0.009 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.287 |
| Book Value Per Share (mrq) | 0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -967271 CAD |
| Levered Free Cash Flow (ttm) | -1357415 CAD |
Profile of Entheon Biomedical Corp.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 999 West Broadway |
| ZIP | V5Z 1K5 |
| Phone | 604-562-3932 |
| Website | https://www.entheonbiomedical.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Q&A For Entheon Biomedical Corp. Stock
What is a current ENBI.CN stock price?
Entheon Biomedical Corp. ENBI.CN stock price today per share is 0.13 CAD.
How to purchase Entheon Biomedical Corp. stock?
You can buy ENBI.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Entheon Biomedical Corp.?
The stock symbol or ticker of Entheon Biomedical Corp. is ENBI.CN.
Which industry does the Entheon Biomedical Corp. company belong to?
The Entheon Biomedical Corp. industry is Biotechnology.
How many shares does Entheon Biomedical Corp. have in circulation?
The max supply of Entheon Biomedical Corp. shares is 5.91M.
What is Entheon Biomedical Corp. Price to Earnings Ratio (PE Ratio)?
Entheon Biomedical Corp. PE Ratio is now.
What was Entheon Biomedical Corp. earnings per share over the trailing 12 months (TTM)?
Entheon Biomedical Corp. EPS is -0.05 CAD over the trailing 12 months.
Which sector does the Entheon Biomedical Corp. company belong to?
The Entheon Biomedical Corp. sector is Healthcare.